BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
2.070
-0.020 (-0.96%)
At close: Dec 5, 2025, 4:00 PM EST
2.030
-0.040 (-1.93%)
After-hours: Dec 5, 2025, 7:48 PM EST
BioXcel Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Dec '25 Dec 5, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 45 | 19 | 86 | 602 | 569 | 1,126 | |
| Market Cap Growth | 75.71% | -78.51% | -85.65% | 5.82% | -49.47% | 327.27% | |
| Enterprise Value | 118 | 83 | 96 | 462 | 317 | 895 | |
| Last Close Price | 2.07 | 5.98 | 47.20 | 343.68 | 325.28 | 739.20 | |
| PS Ratio | 20.66 | 8.19 | 62.58 | 1605.17 | - | - | |
| PB Ratio | - | -0.20 | -1.53 | 7.84 | 2.57 | 5.45 | |
| P/TBV Ratio | - | - | - | 7.84 | 2.57 | 5.45 | |
| EV/Sales Ratio | 157.42 | 36.69 | 69.82 | 1233.33 | - | - | |
| Debt / Equity Ratio | -1.23 | -1.11 | -1.79 | 1.22 | 0.01 | 0.01 | |
| Asset Turnover | 0.02 | 0.04 | 0.01 | 0.00 | - | - | |
| Inventory Turnover | 0.97 | 1.61 | 0.63 | - | - | - | |
| Quick Ratio | 0.96 | 1.35 | 2.40 | 5.90 | 13.98 | 18.00 | |
| Current Ratio | 1.18 | 1.68 | 2.65 | 6.17 | 14.21 | 18.33 | |
| Return on Equity (ROE) | - | - | -1766.94% | -111.08% | -49.93% | -70.35% | |
| Return on Assets (ROA) | -67.31% | -72.30% | -74.95% | -44.81% | -29.10% | -40.13% | |
| Return on Capital (ROIC) | -158.82% | -148.97% | -97.39% | -50.73% | -31.02% | -43.59% | |
| Return on Capital Employed (ROCE) | -721.90% | -402.40% | -361.00% | -92.30% | -48.00% | -39.50% | |
| Earnings Yield | -150.68% | -321.18% | -207.35% | -27.54% | -18.80% | -7.30% | |
| FCF Yield | -128.59% | -388.15% | -179.52% | -22.51% | -14.52% | -5.92% | |
| Buyback Yield / Dilution | -235.79% | -39.21% | -4.00% | -6.23% | -21.63% | -33.11% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.